Detection and prognostic relevance of circulating tumour cells (CTCs) in Asian breast cancers using a label-free microfluidic platform

ClearCell® FX, a label-free microfluidics technology for enrichment of viable circulating tumor cells

(2018) Yifang Lee et al.   CYTOMETRY PART A

Succinct workflows for circulating tumor cells after enrichment: From systematic counting to mutational profiling

(2017) Victor Chun-Lam Wong et al.   PLoS One

Molecular characterization of PDL1 status of circulating tumor cells (CTCs) isolated with a novel label-free inertial microfluidic system from patients (pts) with advanced cancers

(2016) J. Fraser-Fish et al.   ANNALS OF ONCOLOGY

Circulating Tumor Cells: A Review of Non-EpCAM-Based Approaches for Cell Enrichment and Isolation

(2016) M. T. Gabriel et al.   CLINICAL CHEMISTRY

Heterogeneous estrogen receptor expression in circulating tumor cells suggests diverse mechanisms of fulvestrant resistance

(2016) Costanza Paoletti et al.   Molecular Oncology

Prognostic Impact of Circulating Tumor Cell Detected Using a Novel Fluidic Cell Microarray Chip System in Patients with Breast Cancer

(2016) Takeshi Sawada et al.   EBioMedicine

The impact of HER2 phenotype of circulating tumor cells in metastatic breast cancer: a retrospective study in 107 patients

(2015) Markus Wallwiener et al.   BMC CANCER

Correlation of hormone receptor status between circulating tumor cells, primary tumor, and metastasis in breast cancer patients

(2015) K. Kalinsky et al.   Clinical & Translational Oncology

Prognostic value of circulating tumor cells in metastatic breast cancer: a systemic review and meta-analysis

(2015) Q. Lv et al.   Clinical & Translational Oncology

Circulating tumor cells in non-metastatic triple-negative breast cancer

(2014) Mandar Karhade et al.   BREAST CANCER RESEARCH AND TREATMENT

Clinical Validation of an Ultra High-Throughput Spiral Microfluidics for the Detection and Enrichment of Viable Circulating Tumor Cells

(2014) Bee Luan Khoo et al.   PLoS One

Detection and prognostic significance of circulating tumour cells in patients with metastatic breast cancer according to immunohistochemical subtypes

(2013) D J E Peeters et al.   BRITISH JOURNAL OF CANCER

Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update

(2013) Antonio C. Wolff et al.   JOURNAL OF CLINICAL ONCOLOGY

Heterogeneity of Estrogen Receptor Expression in Circulating Tumor Cells from Metastatic Breast Cancer Patients

(2013) Anna Babayan et al.   PLoS One

Isolation and retrieval of circulating tumor cells using centrifugal forces

(2013) Han Wei Hou et al.   Scientific Reports

Clinical application of circulating tumor cells in breast cancer: overview of the current interventional trials

(2012) François-Clément Bidard et al.   CANCER AND METASTASIS REVIEWS

Circulating tumour cells in non-metastatic breast cancer: a prospective study

(2012) Anthony Lucci et al.   LANCET ONCOLOGY

Epithelial-Mesenchymal Transition and Stem Cell Markers in Patients with HER2-Positive Metastatic Breast Cancer

(2012) A. Giordano et al.   MOLECULAR CANCER THERAPEUTICS

Circulating tumor cells in immunohistochemical subtypes of metastatic breast cancer: lack of prediction in HER2-positive disease treated with targeted therapy

(2011) A. Giordano et al.   ANNALS OF ONCOLOGY

HER2-Positive Circulating Tumor Cells in Breast Cancer

(2011) Michail Ignatiadis et al.   PLoS One

Single circulating tumor cell detection and overall survival in nonmetastatic breast cancer

(2009) F.-C. Bidard et al.   ANNALS OF ONCOLOGY

Molecular profiling and predictive value of circulating tumor cells in patients with metastatic breast cancer: an option for monitoring response to breast cancer related therapies

(2008) Mitra Tewes et al.   BREAST CANCER RESEARCH AND TREATMENT